FDA Advisory Meeting Clinical Pharmacology Review Utilizes a Quantitative Systems Pharmacology (QSP) Model: A Watershed Moment?
about
The promises of quantitative systems pharmacology modelling for drug developmentAgent-Based Modeling in Systems PharmacologyImportance of Drug Pharmacokinetics at the Site of ActionA model qualification method for mechanistic physiological QSP models to support model-informed drug development.A Six-Stage Workflow for Robust Application of Systems Pharmacology.Quantitative Systems Pharmacology: A Framework for Context.Disease Systems Analysis of Bone Mineral Density and Bone Turnover Markers in Response to Alendronate, Placebo, and Washout in Postmenopausal Women.Is systems pharmacology ready to impact upon therapy development? A study on the cholesterol biosynthesis pathway.A human tissue-based functional assay platform to evaluate the immune function impact of small molecule inhibitors that target the immune system.MatVPC: A User-Friendly MATLAB-Based Tool for the Simulation and Evaluation of Systems Pharmacology Models.Editorial: The emerging discipline of quantitative systems pharmacology.Disease Progression Modeling: Key Concepts and Recent DevelopmentsMethodologies for Quantitative Systems Pharmacology (QSP) Models: Design and Estimation.Drugs and genetics.Preclinical QSP Modeling in the Pharmaceutical Industry: An IQ Consortium Survey Examining the Current Landscape.How to mathematically optimize drug regimens using optimal control.Impact of amyloid-beta changes on cognitive outcomes in Alzheimer's disease: analysis of clinical trials using a quantitative systems pharmacology model.Complex versus simple models: ion-channel cardiac toxicity prediction.Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situationsA quantitative systems pharmacology (QSP) model for Pneumocystis treatment in micePerspective on the State of Pharmacometrics and Systems Pharmacology Integration
P2860
Q28077650-7063D10D-C004-40F4-9606-F471EF5FE808Q28602444-376706B5-FB61-4203-8F83-20352616CE5FQ33648045-187CAAF9-C637-4FE1-AF8A-592D0EEC1788Q36600060-89EADC2E-B7F3-438C-9C84-A915275D6835Q36933677-413E3DF8-8B4A-4597-8362-FBE1B339DB62Q37200950-B7178613-662A-4D88-BB33-07F84260234EQ37540090-3FA65B44-0F50-448C-93CA-AAB054BF296BQ40046136-EB0B4681-1DB6-4125-90A4-10B39417CA99Q40129952-BC72216E-6DCE-45FC-8864-04E0FEF35BCAQ41425923-0ED2C0A8-5560-4F9A-83B5-174181F7696BQ41602796-921C3797-10D0-4677-B75B-8DB6CCA23A72Q41639443-E747E6EC-7686-4B84-8C6E-D5286D711AD8Q42350410-A99F265C-18E1-4DEB-85FE-D5EAD6422FB6Q47170923-BE9E7D47-ABDD-4826-B9FF-7E4DECE8D68EQ47724152-A4BFA60E-5A0C-4A5D-9794-8DC91664D8C1Q48092932-8718128C-E73C-4D8E-86F6-54D9338D5EA5Q48113629-B1F0C722-8490-49CC-970B-4D889D3EC3D7Q49206501-F2BCA56E-47A4-42F6-A9BB-28B964A690AAQ57171032-1DC73F9D-E8A5-4338-97E9-29F394FA68AFQ57175587-3189F2CC-DDAE-4F7D-8243-D7271FC98008Q58724707-44B5016C-72FD-461B-A700-22230BC2445C
P2860
FDA Advisory Meeting Clinical Pharmacology Review Utilizes a Quantitative Systems Pharmacology (QSP) Model: A Watershed Moment?
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
FDA Advisory Meeting Clinical ...... SP) Model: A Watershed Moment?
@ast
FDA Advisory Meeting Clinical ...... SP) Model: A Watershed Moment?
@en
type
label
FDA Advisory Meeting Clinical ...... SP) Model: A Watershed Moment?
@ast
FDA Advisory Meeting Clinical ...... SP) Model: A Watershed Moment?
@en
prefLabel
FDA Advisory Meeting Clinical ...... SP) Model: A Watershed Moment?
@ast
FDA Advisory Meeting Clinical ...... SP) Model: A Watershed Moment?
@en
P2860
P356
P1476
FDA Advisory Meeting Clinical ...... SP) Model: A Watershed Moment?
@en
P2093
M C Peterson
P2860
P304
P356
10.1002/PSP4.20
P577
2015-03-12T00:00:00Z